abstract |
The present specification relates to methods and compositions for introducing mRNA into stem cells, such as HSPCs, and methods and compositions for delivering gene editing components in vitro to such cells. For example, the present specification relates to modifying gene sequences using CRISPR-Cas9 complexes in HSPCs, and methods and delivery systems for obtaining such genetic modifications in HSPCs. |